Table I.
Characteristics | No. (%) |
---|---|
Age (years) | |
Mean | 59.4 |
Median | 61.0 |
Range | 21–90 |
FIGO stage | |
I | 8 (4.5) |
II | 7 (3.9) |
III | 126 (70.8) |
IV | 31 (17.4) |
Unknown | 6 (3.4) |
Grade | |
1 | 9 (5.1) |
2 | 46 (25.8) |
3 | 119 (66.9) |
Not determined | 4 (2.2) |
Lymph node status | |
N0 | 45 (25.3) |
N1 | 101 (56.7) |
NX | 32 (18.0) |
Postoperative residual tumour | |
Microscopic | 100 (56.2) |
≤1 cm | 29 (16.3) |
>1 cm | 15 (8.4) |
Not determined | 34 (19.1) |
Histological subtype | |
Serous | 148 (83.2) |
Mucinous | 4 (2.2) |
Endometroid | 11 (6.2) |
Others | 13 (7.3) |
Not determined | 2 (1.1) |
Progression-free survival, months | |
Mean | 28.5 |
Median | 15.9 |
Range | 0–176 |
Overall survival, months | |
Mean | 40.6 |
Median | 30.4 |
Range | 1–176 |
FIGO, International Federation of Gynecology and Obstetrics.